Vulvar Vestibulitis Syndrome: an Overview of Non-surgical Treatment
Overview
Reproductive Medicine
Authors
Affiliations
Vulvar vestibulitis syndrome, which represents one of the major cause of dyspareunia, is a puzzling clinical entity. Although many treatment options have been employed, a rationale therapeutic strategy is still not stated. The present article reviews the most popular medical approaches of such entity (biofeedback, tricyclic antidepressants, interferon psychologic-behavioural therapy, diet modification), as well as those to avoid. Tricyclic antidepressants and biofeedback of the pelvic floor muscles represents the first line effective therapy. Moreover, psychological counselling must support any treatment options.
Impact of a single-session psychosocial counseling intervention for women with vulvodynia.
Moravek M, Legocki L, Piper C, Bernard K, Reed B, Haefner H Int J Gynaecol Obstet. 2022; 160(1):202-208.
PMID: 35766991 PMC: 10083978. DOI: 10.1002/ijgo.14321.
Wagner B, Steiner M, Huber D, Crevenna R Wien Klin Wochenschr. 2021; 134(Suppl 1):11-48.
PMID: 33751183 PMC: 8825385. DOI: 10.1007/s00508-021-01827-w.
Immunological and genetic characterization of women with vulvodynia.
Gerber S, Witkin S, Stucki D J Med Life. 2010; 1(4):432-8.
PMID: 20108524 PMC: 5654203.